Cargando…

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

Detalles Bibliográficos
Autores principales: Chen, Jihui, Wang, Zhipeng, Gao, Shouhong, Wu, Kejin, Bai, Fang, Zhang, Qiqiang, Wang, Hongyu, Ye, Qin, Xu, Fengjing, Sun, Hong, Lu, Yunshu, Liu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995568/
https://www.ncbi.nlm.nih.gov/pubmed/33765996
http://dx.doi.org/10.1186/s12935-021-01876-1
_version_ 1783669943482449920
author Chen, Jihui
Wang, Zhipeng
Gao, Shouhong
Wu, Kejin
Bai, Fang
Zhang, Qiqiang
Wang, Hongyu
Ye, Qin
Xu, Fengjing
Sun, Hong
Lu, Yunshu
Liu, Yan
author_facet Chen, Jihui
Wang, Zhipeng
Gao, Shouhong
Wu, Kejin
Bai, Fang
Zhang, Qiqiang
Wang, Hongyu
Ye, Qin
Xu, Fengjing
Sun, Hong
Lu, Yunshu
Liu, Yan
author_sort Chen, Jihui
collection PubMed
description
format Online
Article
Text
id pubmed-7995568
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79955682021-03-26 Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer Chen, Jihui Wang, Zhipeng Gao, Shouhong Wu, Kejin Bai, Fang Zhang, Qiqiang Wang, Hongyu Ye, Qin Xu, Fengjing Sun, Hong Lu, Yunshu Liu, Yan Cancer Cell Int Correction BioMed Central 2021-03-25 /pmc/articles/PMC7995568/ /pubmed/33765996 http://dx.doi.org/10.1186/s12935-021-01876-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Chen, Jihui
Wang, Zhipeng
Gao, Shouhong
Wu, Kejin
Bai, Fang
Zhang, Qiqiang
Wang, Hongyu
Ye, Qin
Xu, Fengjing
Sun, Hong
Lu, Yunshu
Liu, Yan
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
title Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
title_full Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
title_fullStr Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
title_full_unstemmed Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
title_short Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
title_sort correction to: human drug efflux transporter abcc5 confers acquired resistance to pemetrexed in breast cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995568/
https://www.ncbi.nlm.nih.gov/pubmed/33765996
http://dx.doi.org/10.1186/s12935-021-01876-1
work_keys_str_mv AT chenjihui correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT wangzhipeng correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT gaoshouhong correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT wukejin correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT baifang correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT zhangqiqiang correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT wanghongyu correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT yeqin correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT xufengjing correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT sunhong correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT luyunshu correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer
AT liuyan correctiontohumandrugeffluxtransporterabcc5confersacquiredresistancetopemetrexedinbreastcancer